Houston Entrepreneur and Honorary Consul Richard B. Wilkens Joins nanoTox Board

Online, March 2, 2010 (Newswire.com) - AUSTIN, TX, February 25, 2010 - nanoTox, the only company to provide complete risk assessment exclusively for nanoparticles, is pleased to announce that Houston entrepreneur Richard B. Wilkens has joined the board of directors for its parent company, Nano Risk Assessment. Mr. Wilkens was co-founder of numerous successful companies, two of which were recently acquired by Rockwell Collins. He also is Honorary Consul to the Republic of Slovenia.

"We're very excited to have Richard Wilkens' international business experience added to our exceptional board of directors," said Harry Bushong, president of nanoTox. His background in physics and environmental science give him a keen understanding of our scientific procedures and goals. In addition, his track record of building highly successful businesses and his international ties will strengthen our organization further as we work to ensure nanotechnology products and processes are used in the safest manner possible."

Mr. Wilkens is a partner in Transport Facilitator Partners, L.P. and Weather Insight, L.P., which provides tailored weather services to the energy and financial sectors. He co-founded the AR Group and its subsidiaries Air Routing International, Air Security International (ASI Group) and Wilkens Weather Technologies, which were acquired by the communication and aviation electronics solutions company Rockwell Collins in December of 2009.

In 1996, Mr. Wilkens was appointed Honorary Consul for the Republic of Slovenia, and he is a member of the Consular Corps of Houston, the third largest consul organization in the U.S.

Mr. Wilkens received his Masters of Science in Environmental Health Engineering at the University of Texas at Austin. He received his Bachelors degree in Physics from The University of the South in Sewanee, Tennessee.

About nanoTox
Located in Austin, Texas, nanoTox (www.nanotox.com) is the first company to provide complete assessment - and solutions - exclusively for nanoparticles. nanoTox determines the toxicity of its clients' nanoproducts and offers strategies for managing, reducing or eliminating risk to meet state and federal safety guidelines and shorten time to market. Because nanoTox uses methodologies that are performed under recognized international data quality standards (GLP, ISO, etc.) in its laboratories, the results and associated assessments are suitable for use to support regulatory decisions, product registrations, and litigation and for acceptance by the insurance industry.

nanoTox ensures complete client confidentiality for all of its clients, which include companies or entities that require government approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability. For more information, visit www.nanotox.com.